Vincerx Pharma Presents Preclinical Data on VIP236, its Lead Small Molecule Drug Conjugate, at the American Association for Cancer Research Annual Meeting 2021
VIP236 shows enhanced tumor targeting with robust antitumor activity across multiple xenograft models First-in-human studies…